Global Opioid Induced Constipation (OIC) Drug Market Research Report 2026(Status and Outlook)
Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Opioid Induced Constipation (OIC) Drug market size was estimated at USD 2775.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Opioid Induced Constipation (OIC) Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Opioid Induced Constipation (OIC) Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Opioid Induced Constipation (OIC) Drug market.
Global Opioid Induced Constipation (OIC) Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Ironwood Pharmaceuticals
Daiichi Sankyo Co
Pfizer
Progenics Pharmaceuticals
Shionogi &
Allergan
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma
Mundipharma International Limited
Ono Pharmaceutical
Takeda Pharmaceutical Company Limited
Theravance Biopharma
Bausch Health
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
Market Segmentation (by Type)
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Other
Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Opioid Induced Constipation (OIC) Drug Market
Overview of the regional outlook of the Opioid Induced Constipation (OIC) Drug Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Opioid Induced Constipation (OIC) Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Opioid Induced Constipation (OIC) Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Opioid Induced Constipation (OIC) Drug market size was estimated at USD 2775.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Opioid Induced Constipation (OIC) Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Opioid Induced Constipation (OIC) Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Opioid Induced Constipation (OIC) Drug market.
Global Opioid Induced Constipation (OIC) Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Ironwood Pharmaceuticals
Daiichi Sankyo Co
Pfizer
Progenics Pharmaceuticals
Shionogi &
Allergan
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma
Mundipharma International Limited
Ono Pharmaceutical
Takeda Pharmaceutical Company Limited
Theravance Biopharma
Bausch Health
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
Market Segmentation (by Type)
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Other
Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Opioid Induced Constipation (OIC) Drug Market
Overview of the regional outlook of the Opioid Induced Constipation (OIC) Drug Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Opioid Induced Constipation (OIC) Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Opioid Induced Constipation (OIC) Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Opioid Induced Constipation (OIC) Drug
1.2 Key Market Segments
1.2.1 Opioid Induced Constipation (OIC) Drug Segment by Type
1.2.2 Opioid Induced Constipation (OIC) Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 OPIOID INDUCED CONSTIPATION (OIC) DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Opioid Induced Constipation (OIC) Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Opioid Induced Constipation (OIC) Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 OPIOID INDUCED CONSTIPATION (OIC) DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Opioid Induced Constipation (OIC) Drug Product Life Cycle
3.3 Global Opioid Induced Constipation (OIC) Drug Sales by Manufacturers (2020-2025)
3.4 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Opioid Induced Constipation (OIC) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Opioid Induced Constipation (OIC) Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Opioid Induced Constipation (OIC) Drug Market Competitive Situation and Trends
3.8.1 Opioid Induced Constipation (OIC) Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Opioid Induced Constipation (OIC) Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 OPIOID INDUCED CONSTIPATION (OIC) DRUG INDUSTRY CHAIN ANALYSIS
4.1 Opioid Induced Constipation (OIC) Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF OPIOID INDUCED CONSTIPATION (OIC) DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Opioid Induced Constipation (OIC) Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Opioid Induced Constipation (OIC) Drug Market
5.7 ESG Ratings of Leading Companies
6 OPIOID INDUCED CONSTIPATION (OIC) DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2020-2025)
6.3 Global Opioid Induced Constipation (OIC) Drug Market Size by Type (2020-2025)
6.4 Global Opioid Induced Constipation (OIC) Drug Price by Type (2020-2025)
7 OPIOID INDUCED CONSTIPATION (OIC) DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Opioid Induced Constipation (OIC) Drug Market Sales by Application (2020-2025)
7.3 Global Opioid Induced Constipation (OIC) Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Opioid Induced Constipation (OIC) Drug Sales Growth Rate by Application (2020-2025)
8 OPIOID INDUCED CONSTIPATION (OIC) DRUG MARKET SALES BY REGION
8.1 Global Opioid Induced Constipation (OIC) Drug Sales by Region
8.1.1 Global Opioid Induced Constipation (OIC) Drug Sales by Region
8.1.2 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Region
8.2 Global Opioid Induced Constipation (OIC) Drug Market Size by Region
8.2.1 Global Opioid Induced Constipation (OIC) Drug Market Size by Region
8.2.2 Global Opioid Induced Constipation (OIC) Drug Market Size by Region
8.3 North America
8.3.1 North America Opioid Induced Constipation (OIC) Drug Sales by Country
8.3.2 North America Opioid Induced Constipation (OIC) Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Opioid Induced Constipation (OIC) Drug Sales by Country
8.4.2 Europe Opioid Induced Constipation (OIC) Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Region
8.5.2 Asia Pacific Opioid Induced Constipation (OIC) Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Opioid Induced Constipation (OIC) Drug Sales by Country
8.6.2 South America Opioid Induced Constipation (OIC) Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Region
8.7.2 Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 OPIOID INDUCED CONSTIPATION (OIC) DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Opioid Induced Constipation (OIC) Drug by Region(2020-2025)
9.2 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2020-2025)
9.3 Global Opioid Induced Constipation (OIC) Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Opioid Induced Constipation (OIC) Drug Production
9.4.1 North America Opioid Induced Constipation (OIC) Drug Production Growth Rate (2020-2025)
9.4.2 North America Opioid Induced Constipation (OIC) Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Opioid Induced Constipation (OIC) Drug Production
9.5.1 Europe Opioid Induced Constipation (OIC) Drug Production Growth Rate (2020-2025)
9.5.2 Europe Opioid Induced Constipation (OIC) Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Opioid Induced Constipation (OIC) Drug Production (2020-2025)
9.6.1 Japan Opioid Induced Constipation (OIC) Drug Production Growth Rate (2020-2025)
9.6.2 Japan Opioid Induced Constipation (OIC) Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Opioid Induced Constipation (OIC) Drug Production (2020-2025)
9.7.1 China Opioid Induced Constipation (OIC) Drug Production Growth Rate (2020-2025)
9.7.2 China Opioid Induced Constipation (OIC) Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Ironwood Pharmaceuticals
10.1.1 Ironwood Pharmaceuticals Basic Information
10.1.2 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Overview
10.1.3 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Market Performance
10.1.4 Ironwood Pharmaceuticals Business Overview
10.1.5 Ironwood Pharmaceuticals SWOT Analysis
10.1.6 Ironwood Pharmaceuticals Recent Developments
10.2 Daiichi Sankyo Co
10.2.1 Daiichi Sankyo Co Basic Information
10.2.2 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product Overview
10.2.3 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product Market Performance
10.2.4 Daiichi Sankyo Co Business Overview
10.2.5 Daiichi Sankyo Co SWOT Analysis
10.2.6 Daiichi Sankyo Co Recent Developments
10.3 Pfizer
10.3.1 Pfizer Basic Information
10.3.2 Pfizer Opioid Induced Constipation (OIC) Drug Product Overview
10.3.3 Pfizer Opioid Induced Constipation (OIC) Drug Product Market Performance
10.3.4 Pfizer Business Overview
10.3.5 Pfizer SWOT Analysis
10.3.6 Pfizer Recent Developments
10.4 Progenics Pharmaceuticals
10.4.1 Progenics Pharmaceuticals Basic Information
10.4.2 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Overview
10.4.3 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Market Performance
10.4.4 Progenics Pharmaceuticals Business Overview
10.4.5 Progenics Pharmaceuticals Recent Developments
10.5 Shionogi and
10.5.1 Shionogi and Basic Information
10.5.2 Shionogi and Opioid Induced Constipation (OIC) Drug Product Overview
10.5.3 Shionogi and Opioid Induced Constipation (OIC) Drug Product Market Performance
10.5.4 Shionogi and Business Overview
10.5.5 Shionogi and Recent Developments
10.6 Allergan
10.6.1 Allergan Basic Information
10.6.2 Allergan Opioid Induced Constipation (OIC) Drug Product Overview
10.6.3 Allergan Opioid Induced Constipation (OIC) Drug Product Market Performance
10.6.4 Allergan Business Overview
10.6.5 Allergan Recent Developments
10.7 Nektar Therapeutics
10.7.1 Nektar Therapeutics Basic Information
10.7.2 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product Overview
10.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product Market Performance
10.7.4 Nektar Therapeutics Business Overview
10.7.5 Nektar Therapeutics Recent Developments
10.8 Purdue Pharma
10.8.1 Purdue Pharma Basic Information
10.8.2 Purdue Pharma Opioid Induced Constipation (OIC) Drug Product Overview
10.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drug Product Market Performance
10.8.4 Purdue Pharma Business Overview
10.8.5 Purdue Pharma Recent Developments
10.9 S.L.A. Pharma
10.9.1 S.L.A. Pharma Basic Information
10.9.2 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product Overview
10.9.3 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product Market Performance
10.9.4 S.L.A. Pharma Business Overview
10.9.5 S.L.A. Pharma Recent Developments
10.10 Mundipharma International Limited
10.10.1 Mundipharma International Limited Basic Information
10.10.2 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product Overview
10.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product Market Performance
10.10.4 Mundipharma International Limited Business Overview
10.10.5 Mundipharma International Limited Recent Developments
10.11 Ono Pharmaceutical
10.11.1 Ono Pharmaceutical Basic Information
10.11.2 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Overview
10.11.3 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Market Performance
10.11.4 Ono Pharmaceutical Business Overview
10.11.5 Ono Pharmaceutical Recent Developments
10.12 Takeda Pharmaceutical Company Limited
10.12.1 Takeda Pharmaceutical Company Limited Basic Information
10.12.2 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product Overview
10.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product Market Performance
10.12.4 Takeda Pharmaceutical Company Limited Business Overview
10.12.5 Takeda Pharmaceutical Company Limited Recent Developments
10.13 Theravance Biopharma
10.13.1 Theravance Biopharma Basic Information
10.13.2 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product Overview
10.13.3 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product Market Performance
10.13.4 Theravance Biopharma Business Overview
10.13.5 Theravance Biopharma Recent Developments
10.14 Bausch Health
10.14.1 Bausch Health Basic Information
10.14.2 Bausch Health Opioid Induced Constipation (OIC) Drug Product Overview
10.14.3 Bausch Health Opioid Induced Constipation (OIC) Drug Product Market Performance
10.14.4 Bausch Health Business Overview
10.14.5 Bausch Health Recent Developments
10.15 Cosmo Pharmaceuticals SA
10.15.1 Cosmo Pharmaceuticals SA Basic Information
10.15.2 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product Overview
10.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product Market Performance
10.15.4 Cosmo Pharmaceuticals SA Business Overview
10.15.5 Cosmo Pharmaceuticals SA Recent Developments
10.16 Daewoong Pharmaceutical
10.16.1 Daewoong Pharmaceutical Basic Information
10.16.2 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Overview
10.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Market Performance
10.16.4 Daewoong Pharmaceutical Business Overview
10.16.5 Daewoong Pharmaceutical Recent Developments
10.17 C.B. Fleet Company
10.17.1 C.B. Fleet Company Basic Information
10.17.2 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product Overview
10.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product Market Performance
10.17.4 C.B. Fleet Company Business Overview
10.17.5 C.B. Fleet Company Recent Developments
10.18 Sucampo Pharmaceuticals
10.18.1 Sucampo Pharmaceuticals Basic Information
10.18.2 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Overview
10.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Market Performance
10.18.4 Sucampo Pharmaceuticals Business Overview
10.18.5 Sucampo Pharmaceuticals Recent Developments
11 OPIOID INDUCED CONSTIPATION (OIC) DRUG MARKET FORECAST BY REGION
11.1 Global Opioid Induced Constipation (OIC) Drug Market Size Forecast
11.2 Global Opioid Induced Constipation (OIC) Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Opioid Induced Constipation (OIC) Drug Market Size Forecast by Country
11.2.3 Asia Pacific Opioid Induced Constipation (OIC) Drug Market Size Forecast by Region
11.2.4 South America Opioid Induced Constipation (OIC) Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Opioid Induced Constipation (OIC) Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Opioid Induced Constipation (OIC) Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Opioid Induced Constipation (OIC) Drug by Type (2026-2035)
12.1.2 Global Opioid Induced Constipation (OIC) Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Opioid Induced Constipation (OIC) Drug by Type (2026-2035)
12.2 Global Opioid Induced Constipation (OIC) Drug Market Forecast by Application (2026-2035)
12.2.1 Global Opioid Induced Constipation (OIC) Drug Sales (K MT) Forecast by Application
12.2.2 Global Opioid Induced Constipation (OIC) Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Opioid Induced Constipation (OIC) Drug
1.2 Key Market Segments
1.2.1 Opioid Induced Constipation (OIC) Drug Segment by Type
1.2.2 Opioid Induced Constipation (OIC) Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 OPIOID INDUCED CONSTIPATION (OIC) DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Opioid Induced Constipation (OIC) Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Opioid Induced Constipation (OIC) Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 OPIOID INDUCED CONSTIPATION (OIC) DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Opioid Induced Constipation (OIC) Drug Product Life Cycle
3.3 Global Opioid Induced Constipation (OIC) Drug Sales by Manufacturers (2020-2025)
3.4 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Opioid Induced Constipation (OIC) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Opioid Induced Constipation (OIC) Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Opioid Induced Constipation (OIC) Drug Market Competitive Situation and Trends
3.8.1 Opioid Induced Constipation (OIC) Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Opioid Induced Constipation (OIC) Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 OPIOID INDUCED CONSTIPATION (OIC) DRUG INDUSTRY CHAIN ANALYSIS
4.1 Opioid Induced Constipation (OIC) Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF OPIOID INDUCED CONSTIPATION (OIC) DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Opioid Induced Constipation (OIC) Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Opioid Induced Constipation (OIC) Drug Market
5.7 ESG Ratings of Leading Companies
6 OPIOID INDUCED CONSTIPATION (OIC) DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2020-2025)
6.3 Global Opioid Induced Constipation (OIC) Drug Market Size by Type (2020-2025)
6.4 Global Opioid Induced Constipation (OIC) Drug Price by Type (2020-2025)
7 OPIOID INDUCED CONSTIPATION (OIC) DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Opioid Induced Constipation (OIC) Drug Market Sales by Application (2020-2025)
7.3 Global Opioid Induced Constipation (OIC) Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Opioid Induced Constipation (OIC) Drug Sales Growth Rate by Application (2020-2025)
8 OPIOID INDUCED CONSTIPATION (OIC) DRUG MARKET SALES BY REGION
8.1 Global Opioid Induced Constipation (OIC) Drug Sales by Region
8.1.1 Global Opioid Induced Constipation (OIC) Drug Sales by Region
8.1.2 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Region
8.2 Global Opioid Induced Constipation (OIC) Drug Market Size by Region
8.2.1 Global Opioid Induced Constipation (OIC) Drug Market Size by Region
8.2.2 Global Opioid Induced Constipation (OIC) Drug Market Size by Region
8.3 North America
8.3.1 North America Opioid Induced Constipation (OIC) Drug Sales by Country
8.3.2 North America Opioid Induced Constipation (OIC) Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Opioid Induced Constipation (OIC) Drug Sales by Country
8.4.2 Europe Opioid Induced Constipation (OIC) Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Region
8.5.2 Asia Pacific Opioid Induced Constipation (OIC) Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Opioid Induced Constipation (OIC) Drug Sales by Country
8.6.2 South America Opioid Induced Constipation (OIC) Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Region
8.7.2 Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 OPIOID INDUCED CONSTIPATION (OIC) DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Opioid Induced Constipation (OIC) Drug by Region(2020-2025)
9.2 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2020-2025)
9.3 Global Opioid Induced Constipation (OIC) Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Opioid Induced Constipation (OIC) Drug Production
9.4.1 North America Opioid Induced Constipation (OIC) Drug Production Growth Rate (2020-2025)
9.4.2 North America Opioid Induced Constipation (OIC) Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Opioid Induced Constipation (OIC) Drug Production
9.5.1 Europe Opioid Induced Constipation (OIC) Drug Production Growth Rate (2020-2025)
9.5.2 Europe Opioid Induced Constipation (OIC) Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Opioid Induced Constipation (OIC) Drug Production (2020-2025)
9.6.1 Japan Opioid Induced Constipation (OIC) Drug Production Growth Rate (2020-2025)
9.6.2 Japan Opioid Induced Constipation (OIC) Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Opioid Induced Constipation (OIC) Drug Production (2020-2025)
9.7.1 China Opioid Induced Constipation (OIC) Drug Production Growth Rate (2020-2025)
9.7.2 China Opioid Induced Constipation (OIC) Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Ironwood Pharmaceuticals
10.1.1 Ironwood Pharmaceuticals Basic Information
10.1.2 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Overview
10.1.3 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Market Performance
10.1.4 Ironwood Pharmaceuticals Business Overview
10.1.5 Ironwood Pharmaceuticals SWOT Analysis
10.1.6 Ironwood Pharmaceuticals Recent Developments
10.2 Daiichi Sankyo Co
10.2.1 Daiichi Sankyo Co Basic Information
10.2.2 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product Overview
10.2.3 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product Market Performance
10.2.4 Daiichi Sankyo Co Business Overview
10.2.5 Daiichi Sankyo Co SWOT Analysis
10.2.6 Daiichi Sankyo Co Recent Developments
10.3 Pfizer
10.3.1 Pfizer Basic Information
10.3.2 Pfizer Opioid Induced Constipation (OIC) Drug Product Overview
10.3.3 Pfizer Opioid Induced Constipation (OIC) Drug Product Market Performance
10.3.4 Pfizer Business Overview
10.3.5 Pfizer SWOT Analysis
10.3.6 Pfizer Recent Developments
10.4 Progenics Pharmaceuticals
10.4.1 Progenics Pharmaceuticals Basic Information
10.4.2 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Overview
10.4.3 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Market Performance
10.4.4 Progenics Pharmaceuticals Business Overview
10.4.5 Progenics Pharmaceuticals Recent Developments
10.5 Shionogi and
10.5.1 Shionogi and Basic Information
10.5.2 Shionogi and Opioid Induced Constipation (OIC) Drug Product Overview
10.5.3 Shionogi and Opioid Induced Constipation (OIC) Drug Product Market Performance
10.5.4 Shionogi and Business Overview
10.5.5 Shionogi and Recent Developments
10.6 Allergan
10.6.1 Allergan Basic Information
10.6.2 Allergan Opioid Induced Constipation (OIC) Drug Product Overview
10.6.3 Allergan Opioid Induced Constipation (OIC) Drug Product Market Performance
10.6.4 Allergan Business Overview
10.6.5 Allergan Recent Developments
10.7 Nektar Therapeutics
10.7.1 Nektar Therapeutics Basic Information
10.7.2 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product Overview
10.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product Market Performance
10.7.4 Nektar Therapeutics Business Overview
10.7.5 Nektar Therapeutics Recent Developments
10.8 Purdue Pharma
10.8.1 Purdue Pharma Basic Information
10.8.2 Purdue Pharma Opioid Induced Constipation (OIC) Drug Product Overview
10.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drug Product Market Performance
10.8.4 Purdue Pharma Business Overview
10.8.5 Purdue Pharma Recent Developments
10.9 S.L.A. Pharma
10.9.1 S.L.A. Pharma Basic Information
10.9.2 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product Overview
10.9.3 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product Market Performance
10.9.4 S.L.A. Pharma Business Overview
10.9.5 S.L.A. Pharma Recent Developments
10.10 Mundipharma International Limited
10.10.1 Mundipharma International Limited Basic Information
10.10.2 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product Overview
10.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product Market Performance
10.10.4 Mundipharma International Limited Business Overview
10.10.5 Mundipharma International Limited Recent Developments
10.11 Ono Pharmaceutical
10.11.1 Ono Pharmaceutical Basic Information
10.11.2 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Overview
10.11.3 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Market Performance
10.11.4 Ono Pharmaceutical Business Overview
10.11.5 Ono Pharmaceutical Recent Developments
10.12 Takeda Pharmaceutical Company Limited
10.12.1 Takeda Pharmaceutical Company Limited Basic Information
10.12.2 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product Overview
10.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product Market Performance
10.12.4 Takeda Pharmaceutical Company Limited Business Overview
10.12.5 Takeda Pharmaceutical Company Limited Recent Developments
10.13 Theravance Biopharma
10.13.1 Theravance Biopharma Basic Information
10.13.2 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product Overview
10.13.3 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product Market Performance
10.13.4 Theravance Biopharma Business Overview
10.13.5 Theravance Biopharma Recent Developments
10.14 Bausch Health
10.14.1 Bausch Health Basic Information
10.14.2 Bausch Health Opioid Induced Constipation (OIC) Drug Product Overview
10.14.3 Bausch Health Opioid Induced Constipation (OIC) Drug Product Market Performance
10.14.4 Bausch Health Business Overview
10.14.5 Bausch Health Recent Developments
10.15 Cosmo Pharmaceuticals SA
10.15.1 Cosmo Pharmaceuticals SA Basic Information
10.15.2 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product Overview
10.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product Market Performance
10.15.4 Cosmo Pharmaceuticals SA Business Overview
10.15.5 Cosmo Pharmaceuticals SA Recent Developments
10.16 Daewoong Pharmaceutical
10.16.1 Daewoong Pharmaceutical Basic Information
10.16.2 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Overview
10.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Market Performance
10.16.4 Daewoong Pharmaceutical Business Overview
10.16.5 Daewoong Pharmaceutical Recent Developments
10.17 C.B. Fleet Company
10.17.1 C.B. Fleet Company Basic Information
10.17.2 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product Overview
10.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product Market Performance
10.17.4 C.B. Fleet Company Business Overview
10.17.5 C.B. Fleet Company Recent Developments
10.18 Sucampo Pharmaceuticals
10.18.1 Sucampo Pharmaceuticals Basic Information
10.18.2 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Overview
10.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Market Performance
10.18.4 Sucampo Pharmaceuticals Business Overview
10.18.5 Sucampo Pharmaceuticals Recent Developments
11 OPIOID INDUCED CONSTIPATION (OIC) DRUG MARKET FORECAST BY REGION
11.1 Global Opioid Induced Constipation (OIC) Drug Market Size Forecast
11.2 Global Opioid Induced Constipation (OIC) Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Opioid Induced Constipation (OIC) Drug Market Size Forecast by Country
11.2.3 Asia Pacific Opioid Induced Constipation (OIC) Drug Market Size Forecast by Region
11.2.4 South America Opioid Induced Constipation (OIC) Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Opioid Induced Constipation (OIC) Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Opioid Induced Constipation (OIC) Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Opioid Induced Constipation (OIC) Drug by Type (2026-2035)
12.1.2 Global Opioid Induced Constipation (OIC) Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Opioid Induced Constipation (OIC) Drug by Type (2026-2035)
12.2 Global Opioid Induced Constipation (OIC) Drug Market Forecast by Application (2026-2035)
12.2.1 Global Opioid Induced Constipation (OIC) Drug Sales (K MT) Forecast by Application
12.2.2 Global Opioid Induced Constipation (OIC) Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Opioid Induced Constipation (OIC) Drug Market Size by Type (M USD)
Table 4. Global Opioid Induced Constipation (OIC) Drug Market Size by Application
Table 5. Opioid Induced Constipation (OIC) Drug Market Size Comparison by Region (M USD)
Table 6. Global Opioid Induced Constipation (OIC) Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Opioid Induced Constipation (OIC) Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Opioid Induced Constipation (OIC) Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Induced Constipation (OIC) Drug as of 2025)
Table 11. Global Market Opioid Induced Constipation (OIC) Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Opioid Induced Constipation (OIC) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Opioid Induced Constipation (OIC) Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Opioid Induced Constipation (OIC) Drug Sales by Type (K MT)
Table 27. Global Opioid Induced Constipation (OIC) Drug Market Size by Type (M USD)
Table 28. Global Opioid Induced Constipation (OIC) Drug Sales (K MT) by Type (2020-2025)
Table 29. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2020-2025)
Table 30. Global Opioid Induced Constipation (OIC) Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Opioid Induced Constipation (OIC) Drug Market Share by Type (2020-2025)
Table 32. Global Opioid Induced Constipation (OIC) Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global Opioid Induced Constipation (OIC) Drug Sales (K MT) by Application
Table 34. Global Opioid Induced Constipation (OIC) Drug Market Size by Application
Table 35. Global Opioid Induced Constipation (OIC) Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2020-2025)
Table 37. Global Opioid Induced Constipation (OIC) Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Opioid Induced Constipation (OIC) Drug Market Share by Application (2020-2025)
Table 39. Global Opioid Induced Constipation (OIC) Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Opioid Induced Constipation (OIC) Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2020-2025)
Table 42. Global Opioid Induced Constipation (OIC) Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Opioid Induced Constipation (OIC) Drug Market Size by Region (2020-2025)
Table 44. North America Opioid Induced Constipation (OIC) Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America Opioid Induced Constipation (OIC) Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe Opioid Induced Constipation (OIC) Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Opioid Induced Constipation (OIC) Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Opioid Induced Constipation (OIC) Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America Opioid Induced Constipation (OIC) Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Opioid Induced Constipation (OIC) Drug Production (K MT) by Region(2020-2025)
Table 55. Global Opioid Induced Constipation (OIC) Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Opioid Induced Constipation (OIC) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Opioid Induced Constipation (OIC) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Opioid Induced Constipation (OIC) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Opioid Induced Constipation (OIC) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Opioid Induced Constipation (OIC) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Ironwood Pharmaceuticals Basic Information
Table 63. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Overview
Table 64. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Ironwood Pharmaceuticals Business Overview
Table 66. Ironwood Pharmaceuticals SWOT Analysis
Table 67. Ironwood Pharmaceuticals Recent Developments
Table 68. Daiichi Sankyo Co Basic Information
Table 69. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product Overview
Table 70. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Daiichi Sankyo Co Business Overview
Table 72. Daiichi Sankyo Co SWOT Analysis
Table 73. Daiichi Sankyo Co Recent Developments
Table 74. Pfizer Basic Information
Table 75. Pfizer Opioid Induced Constipation (OIC) Drug Product Overview
Table 76. Pfizer Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Pfizer Business Overview
Table 78. Pfizer SWOT Analysis
Table 79. Pfizer Recent Developments
Table 80. Progenics Pharmaceuticals Basic Information
Table 81. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Overview
Table 82. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Progenics Pharmaceuticals Business Overview
Table 84. Progenics Pharmaceuticals Recent Developments
Table 85. Shionogi and Basic Information
Table 86. Shionogi and Opioid Induced Constipation (OIC) Drug Product Overview
Table 87. Shionogi and Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Shionogi and Business Overview
Table 89. Shionogi and Recent Developments
Table 90. Allergan Basic Information
Table 91. Allergan Opioid Induced Constipation (OIC) Drug Product Overview
Table 92. Allergan Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Allergan Business Overview
Table 94. Allergan Recent Developments
Table 95. Nektar Therapeutics Basic Information
Table 96. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product Overview
Table 97. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Nektar Therapeutics Business Overview
Table 99. Nektar Therapeutics Recent Developments
Table 100. Purdue Pharma Basic Information
Table 101. Purdue Pharma Opioid Induced Constipation (OIC) Drug Product Overview
Table 102. Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Purdue Pharma Business Overview
Table 104. Purdue Pharma Recent Developments
Table 105. S.L.A. Pharma Basic Information
Table 106. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product Overview
Table 107. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. S.L.A. Pharma Business Overview
Table 109. S.L.A. Pharma Recent Developments
Table 110. Mundipharma International Limited Basic Information
Table 111. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product Overview
Table 112. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Mundipharma International Limited Business Overview
Table 114. Mundipharma International Limited Recent Developments
Table 115. Ono Pharmaceutical Basic Information
Table 116. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Overview
Table 117. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Ono Pharmaceutical Business Overview
Table 119. Ono Pharmaceutical Recent Developments
Table 120. Takeda Pharmaceutical Company Limited Basic Information
Table 121. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product Overview
Table 122. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Takeda Pharmaceutical Company Limited Business Overview
Table 124. Takeda Pharmaceutical Company Limited Recent Developments
Table 125. Theravance Biopharma Basic Information
Table 126. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product Overview
Table 127. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Theravance Biopharma Business Overview
Table 129. Theravance Biopharma Recent Developments
Table 130. Bausch Health Basic Information
Table 131. Bausch Health Opioid Induced Constipation (OIC) Drug Product Overview
Table 132. Bausch Health Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Bausch Health Business Overview
Table 134. Bausch Health Recent Developments
Table 135. Cosmo Pharmaceuticals SA Basic Information
Table 136. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product Overview
Table 137. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Cosmo Pharmaceuticals SA Business Overview
Table 139. Cosmo Pharmaceuticals SA Recent Developments
Table 140. Daewoong Pharmaceutical Basic Information
Table 141. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Overview
Table 142. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Daewoong Pharmaceutical Business Overview
Table 144. Daewoong Pharmaceutical Recent Developments
Table 145. C.B. Fleet Company Basic Information
Table 146. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product Overview
Table 147. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. C.B. Fleet Company Business Overview
Table 149. C.B. Fleet Company Recent Developments
Table 150. Sucampo Pharmaceuticals Basic Information
Table 151. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Overview
Table 152. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Sucampo Pharmaceuticals Business Overview
Table 154. Sucampo Pharmaceuticals Recent Developments
Table 155. Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 156. Global Opioid Induced Constipation (OIC) Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 157. North America Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 158. North America Opioid Induced Constipation (OIC) Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 159. Europe Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 160. Europe Opioid Induced Constipation (OIC) Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 161. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 162. Asia Pacific Opioid Induced Constipation (OIC) Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 163. South America Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 164. South America Opioid Induced Constipation (OIC) Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 165. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2026-2035) & (Units)
Table 166. Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 167. Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 168. Global Opioid Induced Constipation (OIC) Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 169. Global Opioid Induced Constipation (OIC) Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 170. Global Opioid Induced Constipation (OIC) Drug Sales (K MT) Forecast by Application (2026-2035)
Table 171. Global Opioid Induced Constipation (OIC) Drug Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Opioid Induced Constipation (OIC) Drug Market Size by Type (M USD)
Table 4. Global Opioid Induced Constipation (OIC) Drug Market Size by Application
Table 5. Opioid Induced Constipation (OIC) Drug Market Size Comparison by Region (M USD)
Table 6. Global Opioid Induced Constipation (OIC) Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Opioid Induced Constipation (OIC) Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Opioid Induced Constipation (OIC) Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Induced Constipation (OIC) Drug as of 2025)
Table 11. Global Market Opioid Induced Constipation (OIC) Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Opioid Induced Constipation (OIC) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Opioid Induced Constipation (OIC) Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Opioid Induced Constipation (OIC) Drug Sales by Type (K MT)
Table 27. Global Opioid Induced Constipation (OIC) Drug Market Size by Type (M USD)
Table 28. Global Opioid Induced Constipation (OIC) Drug Sales (K MT) by Type (2020-2025)
Table 29. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2020-2025)
Table 30. Global Opioid Induced Constipation (OIC) Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Opioid Induced Constipation (OIC) Drug Market Share by Type (2020-2025)
Table 32. Global Opioid Induced Constipation (OIC) Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global Opioid Induced Constipation (OIC) Drug Sales (K MT) by Application
Table 34. Global Opioid Induced Constipation (OIC) Drug Market Size by Application
Table 35. Global Opioid Induced Constipation (OIC) Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2020-2025)
Table 37. Global Opioid Induced Constipation (OIC) Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Opioid Induced Constipation (OIC) Drug Market Share by Application (2020-2025)
Table 39. Global Opioid Induced Constipation (OIC) Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Opioid Induced Constipation (OIC) Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2020-2025)
Table 42. Global Opioid Induced Constipation (OIC) Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Opioid Induced Constipation (OIC) Drug Market Size by Region (2020-2025)
Table 44. North America Opioid Induced Constipation (OIC) Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America Opioid Induced Constipation (OIC) Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe Opioid Induced Constipation (OIC) Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Opioid Induced Constipation (OIC) Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Opioid Induced Constipation (OIC) Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America Opioid Induced Constipation (OIC) Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Opioid Induced Constipation (OIC) Drug Production (K MT) by Region(2020-2025)
Table 55. Global Opioid Induced Constipation (OIC) Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Opioid Induced Constipation (OIC) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Opioid Induced Constipation (OIC) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Opioid Induced Constipation (OIC) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Opioid Induced Constipation (OIC) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Opioid Induced Constipation (OIC) Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Ironwood Pharmaceuticals Basic Information
Table 63. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Overview
Table 64. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Ironwood Pharmaceuticals Business Overview
Table 66. Ironwood Pharmaceuticals SWOT Analysis
Table 67. Ironwood Pharmaceuticals Recent Developments
Table 68. Daiichi Sankyo Co Basic Information
Table 69. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product Overview
Table 70. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Daiichi Sankyo Co Business Overview
Table 72. Daiichi Sankyo Co SWOT Analysis
Table 73. Daiichi Sankyo Co Recent Developments
Table 74. Pfizer Basic Information
Table 75. Pfizer Opioid Induced Constipation (OIC) Drug Product Overview
Table 76. Pfizer Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Pfizer Business Overview
Table 78. Pfizer SWOT Analysis
Table 79. Pfizer Recent Developments
Table 80. Progenics Pharmaceuticals Basic Information
Table 81. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Overview
Table 82. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Progenics Pharmaceuticals Business Overview
Table 84. Progenics Pharmaceuticals Recent Developments
Table 85. Shionogi and Basic Information
Table 86. Shionogi and Opioid Induced Constipation (OIC) Drug Product Overview
Table 87. Shionogi and Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Shionogi and Business Overview
Table 89. Shionogi and Recent Developments
Table 90. Allergan Basic Information
Table 91. Allergan Opioid Induced Constipation (OIC) Drug Product Overview
Table 92. Allergan Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Allergan Business Overview
Table 94. Allergan Recent Developments
Table 95. Nektar Therapeutics Basic Information
Table 96. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product Overview
Table 97. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Nektar Therapeutics Business Overview
Table 99. Nektar Therapeutics Recent Developments
Table 100. Purdue Pharma Basic Information
Table 101. Purdue Pharma Opioid Induced Constipation (OIC) Drug Product Overview
Table 102. Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Purdue Pharma Business Overview
Table 104. Purdue Pharma Recent Developments
Table 105. S.L.A. Pharma Basic Information
Table 106. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product Overview
Table 107. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. S.L.A. Pharma Business Overview
Table 109. S.L.A. Pharma Recent Developments
Table 110. Mundipharma International Limited Basic Information
Table 111. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product Overview
Table 112. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Mundipharma International Limited Business Overview
Table 114. Mundipharma International Limited Recent Developments
Table 115. Ono Pharmaceutical Basic Information
Table 116. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Overview
Table 117. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Ono Pharmaceutical Business Overview
Table 119. Ono Pharmaceutical Recent Developments
Table 120. Takeda Pharmaceutical Company Limited Basic Information
Table 121. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product Overview
Table 122. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Takeda Pharmaceutical Company Limited Business Overview
Table 124. Takeda Pharmaceutical Company Limited Recent Developments
Table 125. Theravance Biopharma Basic Information
Table 126. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product Overview
Table 127. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Theravance Biopharma Business Overview
Table 129. Theravance Biopharma Recent Developments
Table 130. Bausch Health Basic Information
Table 131. Bausch Health Opioid Induced Constipation (OIC) Drug Product Overview
Table 132. Bausch Health Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Bausch Health Business Overview
Table 134. Bausch Health Recent Developments
Table 135. Cosmo Pharmaceuticals SA Basic Information
Table 136. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product Overview
Table 137. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Cosmo Pharmaceuticals SA Business Overview
Table 139. Cosmo Pharmaceuticals SA Recent Developments
Table 140. Daewoong Pharmaceutical Basic Information
Table 141. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Overview
Table 142. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Daewoong Pharmaceutical Business Overview
Table 144. Daewoong Pharmaceutical Recent Developments
Table 145. C.B. Fleet Company Basic Information
Table 146. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product Overview
Table 147. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. C.B. Fleet Company Business Overview
Table 149. C.B. Fleet Company Recent Developments
Table 150. Sucampo Pharmaceuticals Basic Information
Table 151. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Overview
Table 152. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Sucampo Pharmaceuticals Business Overview
Table 154. Sucampo Pharmaceuticals Recent Developments
Table 155. Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 156. Global Opioid Induced Constipation (OIC) Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 157. North America Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 158. North America Opioid Induced Constipation (OIC) Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 159. Europe Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 160. Europe Opioid Induced Constipation (OIC) Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 161. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 162. Asia Pacific Opioid Induced Constipation (OIC) Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 163. South America Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 164. South America Opioid Induced Constipation (OIC) Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 165. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2026-2035) & (Units)
Table 166. Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 167. Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 168. Global Opioid Induced Constipation (OIC) Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 169. Global Opioid Induced Constipation (OIC) Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 170. Global Opioid Induced Constipation (OIC) Drug Sales (K MT) Forecast by Application (2026-2035)
Table 171. Global Opioid Induced Constipation (OIC) Drug Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Opioid Induced Constipation (OIC) Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Opioid Induced Constipation (OIC) Drug Market Size (M USD), 2025-2035
Figure 5. Global Opioid Induced Constipation (OIC) Drug Market Size (M USD) (2020-2035)
Figure 6. Global Opioid Induced Constipation (OIC) Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Opioid Induced Constipation (OIC) Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Opioid Induced Constipation (OIC) Drug Product Life Cycle
Figure 13. Opioid Induced Constipation (OIC) Drug Sales Share by Manufacturers in 2025
Figure 14. Global Opioid Induced Constipation (OIC) Drug Revenue Share by Manufacturers in 2025
Figure 15. Opioid Induced Constipation (OIC) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Opioid Induced Constipation (OIC) Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Opioid Induced Constipation (OIC) Drug Revenue in 2025
Figure 18. Industry Chain Map of Opioid Induced Constipation (OIC) Drug
Figure 19. Global Opioid Induced Constipation (OIC) Drug Market PEST Analysis
Figure 20. Global Opioid Induced Constipation (OIC) Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Opioid Induced Constipation (OIC) Drug Market Share by Type
Figure 27. Sales Market Share of Opioid Induced Constipation (OIC) Drug by Type (2020-2025)
Figure 28. Sales Market Share of Opioid Induced Constipation (OIC) Drug by Type in 2025
Figure 29. Market Share of Opioid Induced Constipation (OIC) Drug by Type (2020-2025)
Figure 30. Market Share of Opioid Induced Constipation (OIC) Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Opioid Induced Constipation (OIC) Drug Market Share by Application
Figure 33. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Application in 2025
Figure 35. Global Opioid Induced Constipation (OIC) Drug Market Share by Application (2020-2025)
Figure 36. Global Opioid Induced Constipation (OIC) Drug Market Share by Application in 2025
Figure 37. Global Opioid Induced Constipation (OIC) Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Opioid Induced Constipation (OIC) Drug Market Size by Region (2020-2025)
Figure 40. North America Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Country in 2024
Figure 43. North America Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Opioid Induced Constipation (OIC) Drug Market Size by Country in 2024
Figure 45. U.S. Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Opioid Induced Constipation (OIC) Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Opioid Induced Constipation (OIC) Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Opioid Induced Constipation (OIC) Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Opioid Induced Constipation (OIC) Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Country in 2024
Figure 53. Europe Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Opioid Induced Constipation (OIC) Drug Market Size by Country in 2024
Figure 55. Germany Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Opioid Induced Constipation (OIC) Drug Market Size by Region in 2024
Figure 68. China Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (K MT)
Figure 79. South America Opioid Induced Constipation (OIC) Drug Sales Market Share by Country in 2024
Figure 80. South America Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (M USD)
Figure 81. South America Opioid Induced Constipation (OIC) Drug Market Size by Country in 2024
Figure 82. Brazil Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Opioid Induced Constipation (OIC) Drug Production Market Share by Region (2020-2025)
Figure 103. North America Opioid Induced Constipation (OIC) Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Opioid Induced Constipation (OIC) Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Opioid Induced Constipation (OIC) Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Opioid Induced Constipation (OIC) Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Opioid Induced Constipation (OIC) Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Opioid Induced Constipation (OIC) Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Opioid Induced Constipation (OIC) Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Opioid Induced Constipation (OIC) Drug Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Opioid Induced Constipation (OIC) Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Opioid Induced Constipation (OIC) Drug Market Size (M USD), 2025-2035
Figure 5. Global Opioid Induced Constipation (OIC) Drug Market Size (M USD) (2020-2035)
Figure 6. Global Opioid Induced Constipation (OIC) Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Opioid Induced Constipation (OIC) Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Opioid Induced Constipation (OIC) Drug Product Life Cycle
Figure 13. Opioid Induced Constipation (OIC) Drug Sales Share by Manufacturers in 2025
Figure 14. Global Opioid Induced Constipation (OIC) Drug Revenue Share by Manufacturers in 2025
Figure 15. Opioid Induced Constipation (OIC) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Opioid Induced Constipation (OIC) Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Opioid Induced Constipation (OIC) Drug Revenue in 2025
Figure 18. Industry Chain Map of Opioid Induced Constipation (OIC) Drug
Figure 19. Global Opioid Induced Constipation (OIC) Drug Market PEST Analysis
Figure 20. Global Opioid Induced Constipation (OIC) Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Opioid Induced Constipation (OIC) Drug Market Share by Type
Figure 27. Sales Market Share of Opioid Induced Constipation (OIC) Drug by Type (2020-2025)
Figure 28. Sales Market Share of Opioid Induced Constipation (OIC) Drug by Type in 2025
Figure 29. Market Share of Opioid Induced Constipation (OIC) Drug by Type (2020-2025)
Figure 30. Market Share of Opioid Induced Constipation (OIC) Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Opioid Induced Constipation (OIC) Drug Market Share by Application
Figure 33. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Application in 2025
Figure 35. Global Opioid Induced Constipation (OIC) Drug Market Share by Application (2020-2025)
Figure 36. Global Opioid Induced Constipation (OIC) Drug Market Share by Application in 2025
Figure 37. Global Opioid Induced Constipation (OIC) Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Opioid Induced Constipation (OIC) Drug Market Size by Region (2020-2025)
Figure 40. North America Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Country in 2024
Figure 43. North America Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Opioid Induced Constipation (OIC) Drug Market Size by Country in 2024
Figure 45. U.S. Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Opioid Induced Constipation (OIC) Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Opioid Induced Constipation (OIC) Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Opioid Induced Constipation (OIC) Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Opioid Induced Constipation (OIC) Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Country in 2024
Figure 53. Europe Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Opioid Induced Constipation (OIC) Drug Market Size by Country in 2024
Figure 55. Germany Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Opioid Induced Constipation (OIC) Drug Market Size by Region in 2024
Figure 68. China Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (K MT)
Figure 79. South America Opioid Induced Constipation (OIC) Drug Sales Market Share by Country in 2024
Figure 80. South America Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (M USD)
Figure 81. South America Opioid Induced Constipation (OIC) Drug Market Size by Country in 2024
Figure 82. Brazil Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Opioid Induced Constipation (OIC) Drug Production Market Share by Region (2020-2025)
Figure 103. North America Opioid Induced Constipation (OIC) Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Opioid Induced Constipation (OIC) Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Opioid Induced Constipation (OIC) Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Opioid Induced Constipation (OIC) Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Opioid Induced Constipation (OIC) Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Opioid Induced Constipation (OIC) Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Opioid Induced Constipation (OIC) Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Opioid Induced Constipation (OIC) Drug Market Share Forecast by Application (2026-2035)
